logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xian Wang

Beijing University of Chinese Medicine
H指数:21
被引数:2,120

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial

Efdamrofusp alfa与Aflibercept在新生血管性年龄相关性黄斑变性患者中的疗效与安全性：一项随机、双盲、活性对照、非劣效性、II期临床试验

OPHTHALMOLOGY RETINA
IF5.7
2025-02-010
PRE
Sun, Junran; Song, Yanping; Gong, Yuanyuan; Tao, Liming; Wang, Hong; Shu, Xiangwen; Wen, Ying; Cui, Ling; Ye, Jian; Lu, Shujie; Deng, Junjie; Li, Haoyu; Xu, Yihua; Qian, Lei; Wu, Zhifeng; Bi, Yanlong; Liu, Qinghuai; Xu, Xiangzhong; Wu, Miaoqin; Zhang, Jinglin; Hao, Jilong; Tong, Jianping; Dai, Hong; Wang, Feng; Zhao, Mingwei; Mao, Junfeng; Li, Chaopeng; He, Tao; Pei, Cheng; Liu, Xiaoling; Wang, Xian; Li, Mingxin; Wang, Wei; Zheng, Qinxiang; Guan, Huaijin; Peng, Hui; Fan, Ke; Zhang, Wenfang; Zhu, Dan; Yu, Songping; Wei, Wenbin; Ding, Lin; Li, Jinying; Lu, Peirong; Yan, Ming; Liu, Wei; Jia, Huixun; Sun, Xiaodong
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China

人类表皮生长因子受体2抗体-药物偶联物诱导的间质性肺疾病/肺炎跨学科管理的临床最佳实践: 中国专家共识

CANCER
IF5.1
2024-08-021
PRE
Xu, Chunwei; Chen, Zhanhong; Xia, Yuanli; Shi, Yanxia; Fu, Peifen; Chen, Yiding; Wang, Xian; Zhang, Lili; Li, Hengyu; Chen, Wenyan; Fu, Jianfei; Huang, Liming; Shu, Jingde; Wang, Ouchen; Wu, Weizhu; Xie, Bojian; Wang, Ting; Zhang, Weiping; Shen, Shurong; Li, Qun; Luo, Ting; Zhang, Bin; Xie, Yanru; Wang, Hongxia; Wang, Qian; Wang, Wenxian; Li, Ziming; Song, Zhengbo; Fang, Wenfeng; Zhong, Wenzhao; Zhang, Yongchang; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Wang, Feng; Meng, Rui; Zhu, Youcai; Wang, Lin; Wan, Bing; Wang, Dong; Hao, Yue; Zhou, Jianya; Huang, Long; Zhang, Zhang; Lv, Donglai; Fang, Meiyu; Lu, Yuanzhi; Si, Lu; Song, Yong; Wang, Xiaojia
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

曲妥珠单抗deruxtecan与曲妥珠单抗emtansine治疗HER2-positive转移性乳腺癌: DESTINY-Breast03试验的长期生存分析

NATURE MEDICINE
IF50
2024-06-026
OAAI
Cortes, Javier; Hurvitz, Sara A.; Im, Seock-Ah; Iwata, Hiroji; Curigliano, Giuseppe; Kim, Sung-Bae; Chiu, Joanne W. Y.; Pedrini, Jose L.; Li, Wei; Yonemori, Kan; Bianchini, Giampaolo; Loi, Sherene; Borges, Giuliano S.; Wang, Xian; Bachelot, Thomas; Nakatani, Shunsuke; Ashfaque, Shahid; Liang, Zhengkang; Egorov, Anton; Hamilton, Erika
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago
ADVANCED SCIENCE
IF14.1
2021-10-2910
OAAI
Qiang, Min; Ma, Peixiang; Li, Yu; Liu, Hejun; Harding, Adam; Min, Chenyu; Wang, Fulian; Liu, Lili; Yuan, Meng; Ji, Qun; Tao, Pingdong; Shi, Xiaojie; Li, Zhean; Li, Teng; Wang, Xian; Zhang, Yu; Wu, Nicholas C.; Lee, Chang-Chun D.; Zhu, Xueyong; Gilbert-Jaramillo, Javier; Zhang, Chuyue; Saxena, Abhishek; Huang, Xingxu; Wang, Hou; James, William; Dwek, Raymond A.; Wilson, Ian A.; Yang, Guang; Lerner, Richard A.

研究方向

暂未获取到该数据
孔炜 封面图
孔炜
H 指数:56论文数:378被引数:1.0万
B
Baoqiang Wang
H 指数:17论文数:111被引数:1,024
H
Huaibing Zhao
H 指数:5论文数:19被引数:55
J
Jing Tao
H 指数:55论文数:455被引数:1.0万
L
Lidian Chen
H 指数:54论文数:362被引数:1.0万
L
Liyang Chen
H 指数:19论文数:69被引数:2,008
X
Xueying Huang
H 指数:13论文数:56被引数:1,064
李
李小明
H 指数:25论文数:97被引数:1,657
X
Xiaohong Wei
H 指数:12论文数:49被引数:376
E
Enock Adjei Agyekum
H 指数:10论文数:29被引数:331